Jacobs Levy Equity Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $17.9M | Sell |
19,470
-4,280
| -18% | -$4.34M | 0.08% | 225 |
|
|
2025
Q4 | $25.5M | Buy |
+23,750
| New | +$22.7M | 0.1% | 174 |
|
|
2025
Q3 | – | Sell |
-6,843
| Closed | -$5.33M | – | 1043 |
|
|
2025
Q2 | $5.33M | Sell |
6,843
-11,245
| -62% | -$8.74M | 0.02% | 420 |
|
|
2025
Q1 | $14.9M | Buy |
18,088
+15,071
| +500% | +$12.5M | 0.06% | 271 |
|
|
2024
Q4 | $2.33M | Sell |
3,017
-13,255
| -81% | -$11M | 0.01% | 569 |
|
|
2024
Q3 | $14.4M | Sell |
16,272
-4,609
| -22% | -$4.14M | 0.06% | 278 |
|
|
2024
Q2 | $18.9M | Buy |
20,881
+9,807
| +89% | +$7.84M | 0.08% | 230 |
|
|
2024
Q1 | $8.62M | Buy |
11,074
+8,651
| +357% | +$6.16M | 0.04% | 324 |
|
|
2023
Q4 | $1.41M | Sell |
2,423
-2,060
| -46% | -$1.2M | 0.01% | 665 |
|
|
2023
Q3 | $2.41M | Buy |
+4,483
| New | +$2.31M | 0.01% | 533 |
|
|
2023
Q2 | – | Sell |
-51,687
| Closed | -$17.8M | – | 1035 |
|
|
2023
Q1 | $17.8M | Sell |
51,687
-99,526
| -66% | -$33.6M | 0.11% | 209 |
|
|
2022
Q4 | $55.3M | Buy |
151,213
+145,112
| +2,378% | +$51.5M | 0.37% | 72 |
|
|
2022
Q3 | $1.97M | Buy |
+6,101
| New | +$1.93M | 0.02% | 562 |
|
|
2021
Q1 | – | Sell |
-203,078
| Closed | -$34.3M | – | 1073 |
|
|
2020
Q4 | $34.3M | Sell |
203,078
-156,197
| -43% | -$23.3M | 0.3% | 84 |
|
|
2020
Q3 | $53.2M | Sell |
359,275
-204,763
| -36% | -$31.7M | 0.55% | 39 |
|
|
2020
Q2 | $92.6M | Buy |
564,038
+150,202
| +36% | +$23.1M | 1% | 9 |
|
|
2020
Q1 | $57.4M | Buy |
413,836
+320,315
| +343% | +$44M | 0.74% | 20 |
|
|
2019
Q4 | $12.3M | Buy |
93,521
+65,268
| +231% | +$7.57M | 0.12% | 208 |
|
|
2019
Q3 | $3.16M | Sell |
28,253
-18,524
| -40% | -$2.06M | 0.04% | 419 |
|
|
2019
Q2 | $5.18M | Sell |
46,777
-330
| -0.7% | -$38.9K | 0.07% | 338 |
|
|
2019
Q1 | $6.11M | Sell |
47,107
-68,962
| -59% | -$8.39M | 0.09% | 294 |
|
|
2018
Q4 | $13.4M | Sell |
116,069
-54,250
| -32% | -$6.06M | 0.24% | 112 |
|
|
2018
Q3 | $18.3M | Sell |
170,319
-317,230
| -65% | -$31.7M | 0.26% | 115 |
|
|
2018
Q2 | $41.6M | Buy |
487,549
+4,760
| +1% | +$391K | 0.65% | 12 |
|
|
2018
Q1 | $37.4M | Buy |
482,789
+269,850
| +127% | +$21.7M | 0.62% | 14 |
|
|
2017
Q4 | $18M | Buy |
212,939
+109,620
| +106% | +$9.33M | 0.32% | 103 |
|
|
2017
Q3 | $8.84M | Sell |
103,319
-192,981
| -65% | -$15.8M | 0.17% | 182 |
|
|
2017
Q2 | $24.4M | Sell |
296,300
-45,340
| -13% | -$3.7M | 0.52% | 39 |
|
|
2017
Q1 | $28.7M | Sell |
341,640
-166,737
| -33% | -$13.4M | 0.58% | 33 |
|
|
2016
Q4 | $37.4M | Buy |
508,377
+138,640
| +37% | +$10.3M | 0.72% | 16 |
|
|
2016
Q3 | $29.7M | Buy |
369,737
+151,140
| +69% | +$12.1M | 0.53% | 42 |
|
|
2016
Q2 | $17.2M | Sell |
218,597
-295,021
| -57% | -$22.2M | 0.36% | 70 |
|
|
2016
Q1 | $37M | Sell |
513,618
-60,970
| -11% | -$4.61M | 0.78% | 14 |
|
|
2015
Q4 | $48.4M | Buy |
574,588
+127,820
| +29% | +$10.6M | 0.96% | 16 |
|
|
2015
Q3 | $37.4M | Buy |
446,768
+438,057
| +5,029% | +$37M | 0.77% | 22 |
|
|
2015
Q2 | $727K | Sell |
8,711
-222,929
| -96% | -$17M | 0.01% | 513 |
|
|
2015
Q1 | $16.8M | Sell |
231,640
-259,229
| -53% | -$18.5M | 0.29% | 119 |
|
|
2014
Q4 | $33.9M | Sell |
490,869
-49,010
| -9% | -$3.31M | 0.58% | 39 |
|
|
2014
Q3 | $35M | Sell |
539,879
-690
| -0.1% | -$43.7K | 0.58% | 37 |
|
|
2014
Q2 | $33.6M | Buy |
540,569
+379,602
| +236% | +$22.6M | 0.56% | 38 |
|
|
2014
Q1 | $9.47M | Sell |
160,967
-722,623
| -82% | -$40.3M | 0.16% | 181 |
|
|
2013
Q4 | $45.1M | Sell |
883,590
-3,330
| -0.4% | -$167K | 0.68% | 24 |
|
|
2013
Q3 | $44.6M | Buy |
886,920
+19,280
| +2% | +$1.01M | 0.76% | 20 |
|
|
2013
Q2 | $42.6M | Buy |
+867,640
| New | +$47.2M | 0.75% | 19 |
|
Other funds holding LLY
VCM
VPM
Jacobs Levy Equity Management's LLY Position: Q1 2026 in Review
Jacobs Levy Equity Management reduced its Eli Lilly (LLY) stake by 18% in Q1 2026, selling an estimated $4.34M and leaving 19,470 shares worth $17.9M. The position accounts for 0.08% of the portfolio, ranked #225.
Jacobs Levy Equity Management first reported a position in LLY in Q2 2013 and has held it in 44 quarters since. The position peaked at $92.6M in Q2 2020. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Jacobs Levy Equity Management held 19,470 shares of Eli Lilly worth $17.9M as of Q1 2026.
- Jacobs Levy Equity Management sold 4,280 Eli Lilly shares in Q1 2026, an estimated $4.34M.
- Eli Lilly made up 0.08% of Jacobs Levy Equity Management's portfolio in Q1 2026, its #225 holding.
- Jacobs Levy Equity Management first reported a position in Eli Lilly in Q2 2013 and has held it in 44 quarters since.
- Jacobs Levy Equity Management's Eli Lilly position peaked at $92.6M in Q2 2020.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Jacobs Levy Equity Management's 13F filing for Q1 2026, filed 15 May 2026.